TEMPVA Research Group, Inc. Report issue

Foundation Phase 4
Founded: Temple TX United States

Organization Overview

First Clinical Trial
2010
NCT00633685
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2010

Timeline

NOW
  • Now